ArticleBlood advances2022

Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia.

Yuki Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.